Streptozotocin, but not alloxan, induces DNA repair synthesis in mouse pancreatic islets in vitro

[1]  H. Okamoto Regulation of proinsulin synthesis in pancreatic islets and a new aspect to insulin-dependent diabetes , 1981, Molecular and Cellular Biochemistry.

[2]  A. Slonim,et al.  Protection against streptozotocin-induced diabetes by superoxide dismutase , 2005, Diabetologia.

[3]  S. Sandler,et al.  The partial protective effect of the hydroxyl radical scavenger dimethyl urea on streptozotocin-induced diabetes in the mouse in vivo and in vitro , 1982, Diabetologia.

[4]  D. Hearse,et al.  Autoradiographic study of the distribution and cellular uptake of (14C)-streptozotocin in the rat , 1976, Diabetologia.

[5]  D. Pipeleers,et al.  Selective uptake of alloxan by pancreatic B-cells. , 1982, The Biochemical journal.

[6]  I. Swenne Effects of cyclic AMP on DNA replication and protein biosynthesis in fetal rat islets of Langerhans maintained in tissue culture , 1982, Bioscience reports.

[7]  M. Buse,et al.  Protective role of superoxide dismutase against diabetogenic drugs. , 1982, The Journal of clinical investigation.

[8]  H. Okamoto,et al.  Protection by superoxide dismutase, catalase, and poly(ADP-ribose) synthetase inhibitors against alloxan- and streptozotocin-induced islet DNA strand breaks and against the inhibition of proinsulin synthesis. , 1982, The Journal of biological chemistry.

[9]  D. Pipeleers,et al.  Determinants of the selective toxicity of alloxan to the pancreatic B cell. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[10]  H. Okamoto,et al.  Streptozotocin and alloxan induce DNA strand breaks and poly(ADP–ribose) synthetase in pancreatic islets , 1981, Nature.

[11]  M. Manning,et al.  Diabetes Induced with Multiple Subdiabetogenic Doses of Streptozotocin: Lack of Protection by Exogenous Superoxide Dismutase , 1981, Diabetes.

[12]  S. J. Cooperstein,et al.  15 – Action of Toxic Drugs on Islet Cells , 1981 .

[13]  K. Grankvist Mechanisms of alloxan diabetogenicity , 1981 .

[14]  L. Boquist A NEW HYPOTHESIS FOR ALLOXAN DIABETES , 1980, Acta pathologica et microbiologica Scandinavica. Section A, Pathology.

[15]  P. J. Lewis,et al.  The involvement of poly(ADP-ribose) polymerase in the degradation of NAD caused by gamma-radiation and N-methyl-N-nitrosourea. , 1979, European journal of biochemistry.

[16]  L. Borg,et al.  Effects in vitro of alloxan on the glucose metabolism of mouse pancreatic B-cells. , 1979, The Biochemical journal.

[17]  P C Hanawalt,et al.  DNA repair in bacteria and mammalian cells. , 1979, Annual review of biochemistry.

[18]  E. Jacobson,et al.  Inhibition of poly(ADP‐ribose) polymerase by methylated xanthines and cytokinins , 1978, FEBS letters.

[19]  D. W. Mullins,et al.  A putative role for nicotinamide adenine dinucleotide-promoted nuclear protein modification in the antitumor activity of N-methyl-N-nitrosourea. , 1977, Cancer research.

[20]  W. Claycomb,et al.  Poly(adenosine diphosphate ribose) polymerase activity and nicotinamide adenine dinucleotide in differentiating cardiac muscle. , 1976, The Biochemical journal.

[21]  T. Anderson,et al.  Streptozotocin diabetes. Correlation with extent of depression of pancreatic islet nicotinamide adenine dinucleotide. , 1974, The Journal of clinical investigation.

[22]  C. Hellerström,et al.  Cytotoxic effects of streptozotocin and N-nitrosomethylurea on the pancreatic B cells with special regard to the role of nicotinamide-adenine dinucleotide. , 1974, The Biochemical journal.

[23]  C. Rerup,et al.  Streptozotocin- and alloxan-diabetes in mice. , 1969, European journal of pharmacology.

[24]  K. Taylor,et al.  Potassium ions and the secretion of insulin by islets of Langerhans incubated in vitro. , 1968, The Biochemical journal.

[25]  P. Schein,et al.  The use of nicotinamide to modify the toxicity of streptozotocin diabetes without loss of antitumor activity. , 1967, Cancer research.

[26]  H. Krebs,et al.  Untersuchungen uber die Harnstoffbildung im Tierkörper , 1932 .